Vivo Capital’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$79M Hold
271,116
– – 8.69% 1
2026
Q2
$90.8M Sell
271,116
-67,779
-20% -$21.5M 8.29% 2
2026
Q1
$109M Buy
338,895
+10,000
+3% +$3.09M 9.08% 2
2025
Q4
$96.9M Buy
328,895
+130,000
+65% +$24.2M 6.27% 3
2025
Q3
$10.5M Buy
198,895
+31,295
+19% +$1.52M 0.85% 32
2025
Q2
$7.05M Buy
+167,600
New +$6.38M 0.72% 29

Other funds holding PRAX

Vivo Capital's PRAX Position: Q3 2026 in Review

Vivo Capital held its Praxis Precision Medicines (PRAX) position steady in Q3 2026 at 271,116 shares worth $79M. The position accounts for 8.69% of the portfolio, ranked #1.

Vivo Capital first reported a position in PRAX in Q2 2025 and has held it in 6 quarters since. The position peaked at $109M in Q1 2026. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Vivo Capital held 271,116 shares of Praxis Precision Medicines worth $79M as of Q3 2026.
  • Vivo Capital left its Praxis Precision Medicines share count unchanged in Q3 2026.
  • Praxis Precision Medicines made up 8.69% of Vivo Capital's portfolio in Q3 2026, its #1 holding.
  • Vivo Capital first reported a position in Praxis Precision Medicines in Q2 2025 and has held it in 6 quarters since.
  • Vivo Capital's Praxis Precision Medicines position peaked at $109M in Q1 2026.
  • 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Vivo Capital's 13F filing for Q3 2026, filed 13 Nov 2026.